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Objectives: There is considerable controversy
regarding the signiﬁcance and appropriate treatment of
type II endoleaks (T2L) after EVAR. We report our
long-term experience with T2L management in a large
multicenter registry.
Methods: Between 2000 and 2010, 1736 patients un-
derwent EVAR. The incidence of T2L was observed. Pri-
mary outcomes were mortality and aneurysm-related
mortality (ARM). Secondary outcomes were change in
aneurysm sac size and reintervention.
Results: During the median follow-up of 32.2 months
(interquartile range, 14.2-52.8 months), there were 474
T2L (27.3%). There were no late abdominal aortic aneurysm
ruptures attributable to a T2L. Patients with T2L had no dif-
ference in overall mortality (P ¼ .47) or ARM (P ¼ .26)
compared with those without T2L. A median sac growth
of 5 mm (interquartile range, 2-10 mm) was seen in 46.1%
of patients with T2L. Of these, 11.0% had an additional
type of endoleak. Reintervention occurred in 111 (23.4%)
of all patients with T2L, of which 74%were performed in pa-
tients with sac growth, and was technically successful in
31.5% of cases. Thirty-nine patients (35.1%) underwent lum-
bar embolization, 31 (27.9%) had adjunctive stents placed, 7
(6.3%) had open surgical revision, and 3 (2.7%) had direct sac
injection. Thirty-one patients (27.9%) hadmultiple interven-
tions. After excluding patients with other types of endoleak,
patients with T2L-associated sac growth had no difference in
overall mortality (P ¼ .57) or ARM (P ¼ .09), with or
without reintervention.
Conclusions: In our multicenter EVAR registry, over-
all mortality and ARM were unaffected by the presence of a
T2L. Moreover, patients who were simply observed for
T2L-associated sac growth had similar outcomes as those
who underwent reintervention for the same, suggesting
that concomitant other endoleak types may be the primary
driver of mortality. Our future work will investigate the
most cost-effective ways to select patients for intervention
besides sac growth alone.
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Objectives: To evaluate the implications of thoracic and
abdominal aortic false lumen embolization (FLE) during
thoracic endovascular aortic repair (TEVAR) and endovascu-
lar aneurysm repair (EVAR) for complicated aortic dissections.
Methods: Ninety-six consecutive patients who pre-
sented with complicated acute and chronic type B thoracic
aortic dissections (TAD) who underwent TEVAR with FLE
(n ¼ 32 [33.3%]) and without FLE (n ¼ 52 [54.2%]), as
well as abdominal aortic dissections (AAD) who underwent
EVAR with FLE (n ¼ 4 [4.2%]) and without FLE (n ¼ 8
[8.3%]). In a subset of 26 patients, before FLE, a wireless
cardioMEMS Endosure pressure sensor was placed in the
false lumen and used to quantify the false lumen to systemic
systolic, diastolic, mean, pulse pressure indices. All data
were prospectively collected and outcomes analyzed.
Results: The 30-day mortality in patients with FLE
(n¼ 1 [2.3%]) was signiﬁcantly lower than patients without
FLE (n ¼ 5 [9.6%]), and none of the patients with FLE
developed spinal cord ischemia. After TEVAR and FLE,
nine patients (29.0%) had persistent retrograde false lumen
endoleaks that required repeat embolization procedures.
FLE and complete thrombosis was achieved in 100% of
EVAR patients. At a mean 18-month follow-up, 88% (23
of 26 patients) had a signiﬁcant decrease in all false lumen-
to-systemic pressure indices, and 65% (17 of 26 patients)
had a false lumen remodeling with>5 mmmaximum diam-
eter reduction. At midterm follow-up, there are no thoracic
or abdominal related ruptures, conversions, or deaths.
Conclusions: FLE during TEVAR for complicated
acute and chronic TAD and AAD is associated with a lower
mortality and is effective in reducing false lumen pressures
and maximum diameter. This adjunctive technique should
be consideredwhenmanaging complicated aortic dissections.
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